An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Recruiting · NCT06927999 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 2 | 2026-09-16 | NCT06927999 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ARS Pharmaceuticals, Inc. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bernstein Clinical Research Center, LLC | Cincinnati | United States | 6 |
| Endeavor Health Clinical Trials Center | Glenview | United States | 1 |
| Institute of Allergology IFA Charité - Campus Benjamin Franklin | Hindenburgdamm 30 | Berlin | Germany | 1 |